Mandy reports on daily biopharma developments, writes feature stories and produces Scrip's Finance Watch column. She covers finance, start-ups, dealmaking, clinical trial results, quarterly earnings reports, commercial competition and corporate strategy.

Mandy regularly interviews everyone from big pharma CEOs to biotech start-up founders, enhancing her expertise on industry trends and market dynamics. She also is interested in drug pricing and novel reimbursement strategies, new treatments in areas of true unmet need, diversity in the biopharma industry and novel approaches to drug development. She has been a business reporter since 2000, covering biopharma, biotech law and commercial real estate.

Jessica is a senior editor, contributing most frequently to daily pharmaceutical coverage in Scrip and Pink Sheet. With a lengthy career covering the pharmaceutical sector, she specializes primarily in business and commercial news, launch strategy, M&A and pricing and market access issues.

Puru Gaur, in his role as a Senior Commercial Consultant at Norstella, brings exceptional expertise to the pharmaceutical industry. His key responsibilities involve rigorous commercial analysis, where he evaluates the market performance and potential of pharmaceutical products. He excels in reimbursement analysis, a crucial aspect where he aids Norstella and its subsidiaries in navigating intricate reimbursement landscapes to enhance market access strategies. Puru also contributes significantly to a cross-functional team, focusing on the development of detailed Disease Datapack reports and actively engaging with clients through the “Ask the Analyst” service.